|
YU135378A
(en)
*
|
1977-06-10 |
1982-08-31 |
Science Union Et Cie Francis D |
Process for the manufacture of new piperazine-dithiocarboxylic acid derivatives
|
|
NO156497C
(no)
|
1984-10-18 |
1987-09-30 |
Helge Boe |
Anordning for sammenfoeyning av to plateformede elementer.
|
|
DE3511110A1
(de)
|
1985-03-27 |
1986-10-02 |
Dr. Karl Thomae Gmbh, 7950 Biberach |
Neue pyridazinone, ihre herstellung und diese verbindungen enthaltende arzneimittel
|
|
PH25772A
(en)
|
1985-08-30 |
1991-10-18 |
Novo Industri As |
Insulin analogues, process for their preparation
|
|
FI91859C
(fi)
|
1987-06-17 |
1994-08-25 |
Eisai Co Ltd |
Analogiamenetelmä antiallergisena aineena aktiivisen bentsotiatsolijohdannaisen valmistamiseksi
|
|
DE3837825A1
(de)
|
1988-11-08 |
1990-05-10 |
Hoechst Ag |
Neue insulinderivate, ihre verwendung und eine sie enthaltende pharmazeutische zubereitung
|
|
JP2869561B2
(ja)
*
|
1989-05-22 |
1999-03-10 |
大塚製薬株式会社 |
血小板粘着抑制剤
|
|
JP2637303B2
(ja)
*
|
1991-04-16 |
1997-08-06 |
明治製菓株式会社 |
新規ベンゾチアゾール誘導体
|
|
DE4223589A1
(de)
|
1992-07-17 |
1994-01-20 |
Fluehs Drehtechnik Gmbh |
Ventiloberteil
|
|
WO1994022846A1
(en)
|
1993-03-30 |
1994-10-13 |
Pfizer Inc. |
Compounds enhancing antitumor activity of other cytotoxic agents
|
|
JP3193560B2
(ja)
|
1993-04-16 |
2001-07-30 |
明治製菓株式会社 |
新規ベンゾオキサゾール誘導体
|
|
DE10199011I2
(de)
|
1993-06-21 |
2004-10-14 |
Novo Nordisk As |
ASP-B28-Insulinkristalle.
|
|
PL178466B1
(pl)
|
1993-09-17 |
2000-05-31 |
Novo Nordisk As |
Pochodna insuliny i kompozycja farmaceutyczna do leczenia cukrzycy
|
|
US5504188A
(en)
|
1994-06-16 |
1996-04-02 |
Eli Lilly And Company |
Preparation of stable zinc insulin analog crystals
|
|
US6130217A
(en)
*
|
1995-09-20 |
2000-10-10 |
Pfizer Inc |
Compounds enhancing antitumor activity of other cytotoxic agents
|
|
BR9707003A
(pt)
|
1996-01-17 |
1999-07-20 |
Novo Nordisk As |
Composto processos para preparar o mesmo para tratamento ou de prevenção de doenças do sistema endócrino e para a manufatura de medicamento coposção farmacêutica e utilização de um composto
|
|
JP3520177B2
(ja)
|
1996-05-09 |
2004-04-19 |
明治製菓株式会社 |
セロトニン５−ｈｔ３受容体部分活性薬
|
|
EP0923580A1
(en)
|
1996-07-26 |
1999-06-23 |
Dr. Reddy's Research Foundation |
Thiazolidinedione compounds having antidiabetic, hypolipidaemic, antihypertensive properties, process for their preparation and pharmaceutical compositions thereof
|
|
ATE356830T1
(de)
|
1996-08-30 |
2007-04-15 |
Novo Nordisk As |
Glp-1 derivate
|
|
IL127296A
(en)
|
1996-12-31 |
2003-01-12 |
Reddy Research Foundation |
Heterocyclic compounds, process for their preparation and pharmaceutical compositions containing them
|
|
WO1997041119A1
(en)
|
1997-05-02 |
1997-11-06 |
Dr. Reddy's Research Foundation |
Novel antidiabetic compounds having hypolipidaemic, antihypertensive properties, process for their preparation and pharmaceutical compositions containing them
|
|
US6613942B1
(en)
|
1997-07-01 |
2003-09-02 |
Novo Nordisk A/S |
Glucagon antagonists/inverse agonists
|
|
BR9810378A
(pt)
|
1997-07-01 |
2000-08-29 |
Novo Nordisk As |
Composto,uso do mesmo, composição farmacêutica, e, processos de tratar a diabete do tipo i ou do tipo ii, de tratar a hiperglicemia, e de diminuir a glicose do sangue em um mamìfero
|
|
KR20010021936A
(ko)
|
1997-07-16 |
2001-03-15 |
한센 핀 베네드, 안네 제헤르, 웨이콥 마리안느 |
융합된 1,2,4-티아디아진 유도체, 그의 제조와 사용
|
|
CN1239570A
(zh)
|
1997-07-17 |
1999-12-22 |
索尼公司 |
磁记录介质和使用该介质的磁记录/再现装置
|
|
US6440961B1
(en)
|
1997-10-27 |
2002-08-27 |
Dr. Reddy's Research Foundation |
Tricyclic compounds and their use in medicine: process for their preparation and pharmaceutical compositions containing them
|
|
WO1999019313A1
(en)
|
1997-10-27 |
1999-04-22 |
Dr. Reddy's Research Foundation |
Novel tricyclic compounds and their use in medicine; process for their preparation and pharmaceutical compositions containing them
|
|
EA003527B1
(ru)
|
1997-10-27 |
2003-06-26 |
Агурон Фармасьютикалз, Инк. |
Замещенные 4-аминотиазолы в качестве ингибиторов циклинзависимых киназ
|
|
JP4391597B2
(ja)
|
1997-12-02 |
2009-12-24 |
ドクター・レディーズ・ラボラトリーズ・リミテッド |
抗糖尿病性、低脂質性及び抗高血圧性を有するチアゾリンジオンとオキサゾリジンジオン誘導体
|
|
JPH11199573A
(ja)
*
|
1998-01-07 |
1999-07-27 |
Yamanouchi Pharmaceut Co Ltd |
５ｈｔ３受容体作動薬及び新規ベンゾチアゾール誘導体
|
|
EP1123279A1
(en)
|
1998-10-21 |
2001-08-16 |
Novo Nordisk A/S |
New compounds, their preparation and use
|
|
JP2002527503A
(ja)
|
1998-10-21 |
2002-08-27 |
ノボ ノルディスク アクティーゼルスカブ |
新規化合物類、それらの調製及び使用
|
|
EP1123297A1
(en)
|
1998-10-21 |
2001-08-16 |
Novo Nordisk A/S |
New compounds, their preparation and use
|
|
EP1123268A1
(en)
|
1998-10-21 |
2001-08-16 |
Novo Nordisk A/S |
New compounds, their preparation and use
|
|
JP2002527501A
(ja)
|
1998-10-21 |
2002-08-27 |
ノボ ノルディスク アクティーゼルスカブ |
新規化合物、その製造及び利用
|
|
AU6325599A
(en)
|
1998-10-21 |
2000-05-08 |
Dr. Reddy's Research Foundation |
New compounds, their preparation and use
|
|
WO2000029409A1
(de)
|
1998-11-17 |
2000-05-25 |
Bayer Aktiengesellschaft |
Neue heterocyclyl-substituierte oxazolidon-derivate
|
|
TW520370B
(en)
*
|
1998-11-20 |
2003-02-11 |
Meiji Seika Kaisha |
Benzooxazole derivatives and a pharmaceutical composition containing the derivatives as an active ingredient
|
|
CA2353907A1
(en)
|
1998-12-18 |
2000-06-29 |
John Bondo Hansen |
Fused 1,2,4-thiadiazine derivatives, their preparation and use
|
|
WO2000041121A1
(en)
|
1999-01-07 |
2000-07-13 |
Ccrewards.Com |
Method and arrangement for issuance and management of digital coupons and sales offers
|
|
JP2002534512A
(ja)
|
1999-01-15 |
2002-10-15 |
ノボ ノルディスク アクティーゼルスカブ |
非ペプチドｇｌｐ−１アゴニスト
|
|
WO2000063189A1
(en)
|
1999-04-16 |
2000-10-26 |
Novo Nordisk A/S |
Crystalline r- guanidines, arginine or (l) -arginine (2s) -2- ethoxy -3-{4- [2-(10h -phenoxazin -10-yl)ethoxy]phenyl}propanoate
|
|
AU2953699A
(en)
|
1999-04-16 |
2000-11-02 |
Dr. Reddy's Research Foundation |
Novel polymorphic forms of an antidiabetic agent: process for their preparation and a pharmaceutical composition containing them
|
|
HRP20010748A2
(en)
|
1999-04-16 |
2003-02-28 |
Reddys Lab Ltd Dr |
Novel polymorphic forms of an antidiabetic agent: process for their preparation and pharmaceutical compositions containing them
|
|
AU3958200A
(en)
|
1999-04-20 |
2000-11-02 |
Novo Nordisk A/S |
New compounds, their preparation and use
|
|
JP2002542237A
(ja)
|
1999-04-20 |
2002-12-10 |
ノボ ノルディスク アクティーゼルスカブ |
新規な化合物、それらの製造及び使用
|
|
AU3958100A
(en)
|
1999-04-20 |
2000-11-02 |
Novo Nordisk A/S |
New compounds, their preparation and use
|
|
CN1348439A
(zh)
|
1999-04-20 |
2002-05-08 |
诺沃挪第克公司 |
新化合物及其制备和用途
|
|
GB0003254D0
(en)
|
2000-02-11 |
2000-04-05 |
Darwin Discovery Ltd |
Heterocyclic compounds and their therapeutic use
|
|
ATE430730T1
(de)
|
2000-03-31 |
2009-05-15 |
Ortho Mcneil Pharm Inc |
Phenyl-substituierte indole als h3 histaminrezeptorantagonisten
|
|
AU2001251083A1
(en)
|
2000-03-31 |
2001-10-15 |
Ortho-Mcneil Pharmaceutical, Inc. |
Method for using 2-aryloxyalkylaminobenzoxazoles and 2-aryloxyalkylaminobenzothiazoles as h3 antagonists
|
|
ES2311534T3
(es)
|
2000-08-10 |
2009-02-16 |
Mitsubishi Tanabe Pharma Corporation |
Derivados de prolina y su uso como farmacos.
|
|
US20030073672A1
(en)
|
2001-09-05 |
2003-04-17 |
Breitenbucher J. Guy |
Method for treating allergies using substituted pyrazoles
|
|
US7576084B2
(en)
|
2001-10-12 |
2009-08-18 |
Choongwae Pharma Corporation |
Reverse-turn mimetics and method relating thereto
|
|
PL372390A1
(en)
*
|
2002-02-05 |
2005-07-25 |
Novo Nordisk A/S |
Novel aryl- and heteroarylpiperazines
|
|
US7449464B2
(en)
*
|
2003-03-12 |
2008-11-11 |
Kudos Pharmaceuticals Limited |
Phthalazinone derivatives
|
|
CA2524787A1
(en)
*
|
2003-05-07 |
2004-11-25 |
Abbott Laboratories |
Fused bicyclic-substituted amines as histamine-3 receptor ligands
|
|
TW200538433A
(en)
|
2004-02-24 |
2005-12-01 |
Irm Llc |
Immunosuppressant compounds and compositiions
|
|
BRPI0617534A2
(pt)
|
2005-09-23 |
2011-07-26 |
Memory Pharm Corp |
Composto, composição farmacêutica, método para a ativação/estimulação seletiva de receptores nicotínicos de a-7 em um paciente, método para o tratamento de um paciente que sofre de uma doença psicótica, uma doença neurodegenerativa que envolve uma disfunção do sistema colinérgico, e/ou uma condição de degeneração da memória e/ou da cognição, método para o tratamento de um paciente que sofre de demência e/ou uma outra condição com perda da memória, método para o tratamento de um paciente que sofre de degeneração da memória devida à degeneração cognitiva suave devida ao envelhecimento, mal de alzheimer, esquizofrenia, mal de parkinson, mal de huntington, mal de pick, mal de creutzfeldt-jakob, depressão, envelhecimento, trauma na cabeça, acidente vascular cerebral, hipoxia do cns, senilidade cerebral, demência de multiinfarto, hiv e/ou doença cardiovascular, método para o tratamento e/ou a prevenção da demência em um paciente com mal de alzheimer, método para o tratamento de um paciente para a retirada do álcool ou para o tratamento de um paciente com terapia anti-intoxicação, método para o tratamento de um paciente para conferir neuroproteção contra os danos associados com acidentes vasculares cerebrais e isquemia e excitotoxicidade induzida por glutamato, método para o tratamento de um paciente que sofre de vício de nicotina, dor, tontura de fuso horário, obesidade e/ou diabetes, método de indução de um paciente a parar de fumar, método para o tratamento de um paciente que sofre de degeneração cognitiva suave (mci), demência vascular (vad), declínio cognitivo associado com a idade (aacd), amnésia associada com a cirurgia de coração aberto, apreensão cardíaca, anestesia geral, déficits da memória devido à exposição a agentes anestésicos(...)
|